Concentra Group Holdings Parent Inc 2025年季度报告

an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growthcompany” in Rule12b-2 of the Exchange Act. (Check one): Non-accelerated filer☒Smaller reporting companyEmerging Growth Company new or revised financial accounting standards provided pursuant to Section13(a)of the Exchange Act.☐Indicate by check mark whether the Registrant is a shell company (as defined in Rule12b-2 of the Exchange Act).Yes☐No☒ Net (decrease) increase in cashCash at beginning of period The accompanying notes are an integral part of these condensed consolidated financial statements. 1.OrganizationConcentra Group Holdings Parent, Inc., a Delaware corporation, conducts substantially all of its business through ConcentraHealth Services, Inc. (“CHSI”) and its subsidiaries. As the context may require, the “Company,” “we,” “our” or similar words in thisreport refer collectively to Concentra and its subsidiaries. Basis of Presentation and ConsolidationThe Company operated as part of Select Medical Corporation (“Select”) until Select made a special stock distribution of104,093,503shares of the Company’s common stock to Select’s stockholders (the “Distribution”) on November 25, 2024. The standalone basis. The unaudited condensed consolidated financial statements of the Company as of March31, 2025, and for the threemonths ended March31, 2025 and 2024, have been prepared pursuant to the rules and regulations of the Securities and ExchangeCommission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S.GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to theconsolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Companybelieves the disclosure is adequate to make the information presented not misleading. In the opinion of management, such informationcontains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of Annual Report on Form 10-K for the year ended December 31, 2024 (File No. 001-42188).The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entitystructure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions thatare partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefitsadministration, procurement support, information technology, legal, corporate governance and other professional services. Indirect based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated incometax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in Select’sconsolidated income tax provision, were assumed to be immediately settled with Select through contributed capital/capital in excess ofpar as reflected on the condensed consolidated balance sheets, and reflected as a (distribution)/contribution to Select on the condensed financing activities.8 entities in which the Company has a controlling financial interest. All intercompany balances and transactions within the Company areeliminated in consolidation. Transactions between the Company and Select have been included in these condensed consolidated financial statements. The transactions with Select are settled in cash, other than the assumed income tax settlement noted above, andare reflected within the condensed consolidated statement of cash flows as an operating or financing activity determined by the natureof the transaction. The Company is exposed to certain risks relating to its ongoing financial arrangements. The primary risk managed usingderivative instruments is to reduce variability in interest cash flows on its variable-rate debt. Interest rate swaps and collars are enteredinto to manage interest rate risk associated with the Company’s variable-rate debt. As a matter of policy, we do not use highly ASC 815 requires entities to recognize all derivative instruments as either assets or liabilities in the statement of financialposition at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whetherit has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship.Our designated derivative contracts include interest rate swap and collar agreements, which effectively modify the Company’s changes on future interest expense. These agreements involve the receipt of flo